Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...
المؤلفون الرئيسيون: | Ahmed, T, Tina Ahmed |
---|---|
مؤلفون آخرون: | Hanke, T |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2014
|
الموضوعات: |
مواد مشابهة
-
The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
حسب: Wan, L, وآخرون
منشور في: (2012) -
Architecture of the HIV-1 glycan shield
حسب: Pritchard, L
منشور في: (2014) -
HIV-specific interleukin-10 responses and immune modulation
حسب: Clutton, G
منشور في: (2012) -
Antibody-based HIV-1 vaccines: recent developments and future directions
حسب: Montefiori, D, وآخرون
منشور في: (2007) -
T-cell receptor (TCR) usage in HIV-2 infection
حسب: Moysi, E
منشور في: (2012)